Sotac Pharmaceuticals Limited has provided clarification regarding recent price movements of its shares.

The company stated it has disclosed all pertinent information affecting its operations and performance, adhering to regulations governing timely communication with exchanges and stakeholders.

There are no pending announcements or material information withheld that could influence the stock's price behavior.

The company attributes recent price fluctuations to market sentiment and the demand-supply dynamics among existing and potential investors, asserting that these movements are entirely market-driven, with no direct involvement or control from the company's management.